GORE TIGRIS, a Third Generation Stent with Flexibility, Strength, Anti-Thrombus Technology, FDA Approved

W. L. Gore & Associates, better known as just Gore, won FDA approval for its GORE TIGRIS vascular stent. The device combines traditional nitinol metal with fluoropolymer interconnections. This gives it impressive strength and flexibility to resist the mechanical forces applied by either superficial femoral artery (SFA) or proximal popliteal artery (PPA), depending on the site of implantation. In a study that led to the FDA approval, the GORE TIGRIS had no fractures at all while 27% of the control devices experienced fractures.

The GORE TIGRIS also uses the firm's CBAS Heparin Surface, a blood thinning component that helps prevent thrombi from forming around the stent. This technology bonds the heparin to the stent while keeping the other side free to react with the blood passing by.

From GORE:

The evolution of peripheral stenting over the past decade has allowed for broader adoption of endovascular therapy for treating PAD. When physicians began placing stents in the SFA they were limited by first generation stent designs that had longitudinal metal connections which led to arterial stiffening, high fracture rates and poorer clinical outcomes. Improvements in second generation devices introduced helical interconnections to improve flexibility; however, their success in high flexion vessels, like the distal SFA and PPA, was still limited.* The introduction of third generation stents, including the GORE TIGRIS Vascular Stent, allow for better adherence in some of the more intricate vessels in the body.

Product page: GORE TIGRIS Vascular Stent…

Via: GORE…

This post GORE TIGRIS, a Third Generation Stent with Flexibility, Strength, Anti-Thrombus Technology, FDA Approved appeared first on Medgadget.

from #MedicinebyAlexandrosSfakianakis via xlomafota13 on Inoreader http://ift.tt/2b8cEce
via IFTTT